ARVN Net Margin
2.94%TTM
Period ending:
ARVN FY Net Margin%
21.69%-520.35%
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ARVN net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -30.7692% | |
| -75.5125% | |
| -467.8981% | |
| -214.9924% | |
| -356.3433% | |
| -460.6178% | |
| -163.5598% | |
| -289.5888% | |
| -317.3189% | |
| -215.1836% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All ARVN financial metrics · ARVN stock overview · How to interpret financial metrics
